Comparison of screening indicators for different types of thalassemia carriers in Hunan Province

Hua Tang1, Rong Yu2, Ziyin Yu1

  • 1Maternal and Child Health Hospital of Hunan Province, Department of Medical Genetic, Changsha City, Hunan Province, China.

Insights

This study evaluated common indicators for identifying alpha, beta, and compound alpha-beta thalassemia carriers in Hunan Province. Findings aid in distinguishing carrier types for effective thalassemia prevention.

Area of Science:

  • Genetics
  • Hematology
  • Public Health

Background:

  • Thalassemia carrier screening is crucial for preventing the genetic blood disorder.
  • Variations in race and genotype affect standard indicators like MCV, MCH, and HbA2.
  • Accurate identification of different thalassemia types is essential for effective screening.

Purpose of the Study:

  • To evaluate common screening indicators for alpha, beta, and compound alpha-beta thalassemia carriers in Hunan Province.
  • To assess the utility of existing formulas in predicting and differentiating thalassemia carrier types.
  • To improve the accuracy of thalassemia carrier identification in the region.

Main Methods:

  • Utilized receiver operating characteristic (ROC) curve analysis combined with the Youden index.
  • Analyzed data from blood routine examinations and hemoglobin electrophoresis.
  • Applied literature-related formulas to a cohort of 1111 alpha-thalassemia, 464 beta-thalassemia, and 24 compound alpha-beta thalassemia carriers.

Main Results:

  • Identified optimal screening indicators and formulas for distinguishing between different thalassemia carrier types.
  • Demonstrated the effectiveness of ROC curve analysis in evaluating diagnostic accuracy.
  • Provided a basis for refined thalassemia screening protocols in Hunan Province.

Conclusions:

  • Common screening indicators, when analyzed with ROC curves and specific formulas, can effectively differentiate between alpha, beta, and compound alpha-beta thalassemia carriers.
  • The study provides a validated approach for improving the accuracy of thalassemia carrier screening in the studied population.
  • Refined screening strategies based on these findings can enhance the prevention of thalassemia.
Abstract